Literature DB >> 12427069

Expression of somatostatin receptors 1 and 2 in human choroid plexus and arachnoid granulations: implications for idiopathic intracranial hypertension.

Steven E Katz1, Dino D Klisovic, M Sue O'Dorisio, Richard Lynch, Martin Lubow.   

Abstract

OBJECTIVE: To investigate the localization of somatostatin receptor types 1 and 2 in human choroid plexus (CP) and arachnoid granulations (AGs) by immunohistochemistry.
METHODS: A prospective study was performed in an institutional setting. Immunohistochemistry was performed on 15 samples of CP and 12 samples of AGs from 15 patients who died with no signs or symptoms of intracranial disease (age range, 52-81 years). The CP samples were dissected from the lateral ventricles and AG samples were dissected from the superior sagittal sinus.
RESULTS: We demonstrated the presence of both somatostatin receptor types 1 and 2 in all samples of normal human CP and AGs.
CONCLUSIONS: Analogous to their demonstration and to their function in kidney and ocular tissues, these receptors may be involved in the processes of cerebrospinal fluid production and absorption, and may play a role in the increased intracranial pressure of idiopathic intracranial hypertension. CLINICAL RELEVANCE: Somatostatin analogues have been used to treat idiopathic intracranial hypertension, a disorder of cerebrospinal fluid homeostasis. Data are scarce regarding the cell-specific distribution of somatostatin receptors in normal human CP and AGs, the sites of cerebrospinal fluid production and egress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427069     DOI: 10.1001/archopht.120.11.1540

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 2.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

3.  A Natural History of Silent Brain Syndrome over 36 Years: A case report.

Authors:  Nathan Pirakitikulr; David T Tse
Journal:  Orbit       Date:  2021-03-16

4.  Topiramate is more effective than acetazolamide at lowering intracranial pressure.

Authors:  William J Scotton; Hannah F Botfield; Connar Sj Westgate; James L Mitchell; Andreas Yiangou; Maria S Uldall; Rigmor H Jensen; Alex J Sinclair
Journal:  Cephalalgia       Date:  2018-06-13       Impact factor: 6.292

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.